Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-08-31 | Michael Dawson, M.D. |
| 2024-02-06 | Michael Dawson, M.D.(13) Includes 300 shares of common stock. Dr. Dawson ceased to be an officer of the Company effective October 11, 2022. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-26